86 related articles for article (PubMed ID: 3018386)
1. Lymphoblastoid B cell lines produce an interleukin-1-like activity that can be serologically distinct from macrophage interleukin-1.
Valentine M; Lotz M; Dinarello CA; Carson DA; Vaughan JH
Lymphokine Res; 1986; 5(3):173-83. PubMed ID: 3018386
[TBL] [Abstract][Full Text] [Related]
2. IL 1-like activity in antigen-presenting human B cell lines.
Gerrard TL; Volkman DJ
J Immunol; 1985 Nov; 135(5):3217-23. PubMed ID: 2995488
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
4. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS
J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
[TBL] [Abstract][Full Text] [Related]
5. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine-mediated induction of antigen-presenting ability in thymic stromal cells.
Ransom J; Fischer M; Mercer L; Zlotnik A
J Immunol; 1987 Oct; 139(8):2620-8. PubMed ID: 3116089
[TBL] [Abstract][Full Text] [Related]
8. The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.
Maly FE; Cross AR; Jones OT; Wolf-Vorbeck G; Walker C; Dahinden CA; De Weck AL
J Immunol; 1988 Apr; 140(7):2334-9. PubMed ID: 2832475
[TBL] [Abstract][Full Text] [Related]
9. Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.
Matsushima K; Akahoshi T; Yamada M; Furutani Y; Oppenheim JJ
J Immunol; 1986 Jun; 136(12):4496-502. PubMed ID: 3011895
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell lines.
Jochems GJ; Klein MR; Jordens R; Pascual-Salcedo D; van Boxtel-Oosterhof F; van Lier RA; Zeijlemaker WP
Hum Antibodies Hybridomas; 1991 Apr; 2(2):57-64. PubMed ID: 1651786
[TBL] [Abstract][Full Text] [Related]
11. Effect of IL-6 on proliferation and IG production of human EBV-transformed cell lines in serum free culture media.
Jochems GJ; Jordens R; van Lier RA; Zeijlemaker WP
Dev Biol Stand; 1990; 71():57-63. PubMed ID: 2169441
[TBL] [Abstract][Full Text] [Related]
12. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
Stuart AD; Stewart JP; Arrand JR; Mackett M
Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
[TBL] [Abstract][Full Text] [Related]
14. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
15. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells.
Issekutz T; Chu E; Geha RS
J Immunol; 1982 Oct; 129(4):1446-50. PubMed ID: 6286767
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 2 production by a marmoset B cell line.
Brent LH; Miyawaki T; Everson MP; Butler JL
Eur J Immunol; 1990 May; 20(5):1125-9. PubMed ID: 2162776
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.
Stewart JP; Behm FG; Arrand JR; Rooney CM
Virology; 1994 May; 200(2):724-32. PubMed ID: 8178456
[TBL] [Abstract][Full Text] [Related]
18. Characterization of antigen processing and presentation by resting B lymphocytes.
Gosselin EJ; Tony HP; Parker DC
J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
[TBL] [Abstract][Full Text] [Related]
19. A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells.
Friend SL; Hosier S; Nelson A; Foxworthe D; Williams DE; Farr A
Exp Hematol; 1994 Mar; 22(3):321-8. PubMed ID: 8112430
[TBL] [Abstract][Full Text] [Related]
20. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
